Journal article

Therapeutic management of ocular adnexal MALT lymphoma

Andres JM Ferrari, Andrea Assanelli, Roberto Crocchiolo, Giuseppina P Dognini, Antonio Giordano Resti, Letterio S Politi, Claudio Doglioni, Federico Caligaris Cappio, Riccardo Dolcetti, Maurilio Ponzoni

EXPERT OPINION ON PHARMACOTHERAPY | TAYLOR & FRANCIS LTD | Published : 2007

Abstract

Non-Hodgkin lymphomas constitute 50% of all orbital malignancies. Mucosa-associated lymphoid tissue (MALT)-type lymphoma is the most common histology category in this anatomic region. Ocular adnexal lymphoma of MALT-type is an indolent and rarely lethal malignancy that can often be managed with observation alone. Occasionally, lymphomatous lesions determine the symptoms that condition a patient's quality of life, and so require an immediate antineoplastic treatment. Several strategies are available, but reliable indications supported by prospective trials do not exist. Some therapeutic strategies are associated with substantial side effects and require a well-balanced therapeutic decision, w..

View full abstract